Nanalysis Scientific Corp. (NSCI.V)
| Previous Close | 0.9600 |
| Open | 0.9700 |
| Bid | 0.9500 x N/A |
| Ask | 0.9700 x N/A |
| Day's Range | 0.9600 - 0.9700 |
| 52 Week Range | 0.8600 - 1.7600 |
| Volume | |
| Avg. Volume | 73,275 |
| Market Cap | 91.24M |
| Beta (5Y Monthly) | 1.30 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0420 |
| Earnings Date | Aug 25, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.25 |
- CNW Group
Nanalysis Announces Second Quarter 2022 Conference Call
Nanalysis Scientific Corp. ("the Company", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications announces that on Thursday, August 25, 2022, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Interim Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter June 30, 2022.
- CNW Group
Nanalysis Scientific Corp. Announces Management Transitions
Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") announces that the current CFO, Luke Caplette, is stepping down as CFO, but will remain with the Company as a part-time consultant to assist the transition to a new CFO. The Company is pleased that its Corporate Controller, Randall McRae, has been appointed interim-CFO.
- Simply Wall St.
Is Nanalysis Scientific (CVE:NSCI) A Risky Investment?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
